Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-22T17:26:12.887Z Has data issue: false hasContentIssue false

Rapid improvement of severe anorexia nervosa during treatment with ethyl-eicosapentaenoate and micronutrients

Published online by Cambridge University Press:  16 April 2020

Agnes K. Ayton*
Affiliation:
Huntercombe Stafford Hospital, Ivetsey Bank, Wheaton Aston, Stafford, ST17 0XA, UK
Amer Azaz
Affiliation:
Hull Royal Infirmary, Department of Paediatrics, Anlaby Road, Hull, HU3 2JZ, UK
David F. Horrobin
Affiliation:
Laxdale Research, Kings Park House, Laurelhill Business Park, Stirling, FK7 9JQ, UK
*
*Corresponding author. E-mail address: [email protected] (A.K. Ayton).
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Case report
Copyright
Copyright © 2004 European Psychiatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ben Tovim, DIWalker, KGilchrist, PFreeman, RKalucy, REsterman, AOutcome in patients with eating disorders: a 5-year study. Lancet 2001;357:1254–7.CrossRefGoogle ScholarPubMed
Connor, WEImportance of n-3 fatty acids in health and disease. Am J Clin Nutr 2000;71:171S–5S.CrossRefGoogle ScholarPubMed
Heird, WCThe role of polyunsaturated fatty acids in term and preterm infants and breastfeeding mothers. Pediatric Clin N Am 2001;48:173–88.CrossRefGoogle ScholarPubMed
Holman, RTAdams, CENelson, RAGrater, SJJaskiewicz, JAJohnson, SBet al. Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J Nutr 1995;125:901–7.Google ScholarPubMed
Johnson, JGCohen, PKasen, SBrook, JSEating disorders during adolescence and the risk for physical and mental disorders during early adulthood. Arch Gen Psychiatry 2002;59:545–52.CrossRefGoogle ScholarPubMed
Nemets, BStahl, ZBelmaker, RHAddition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477–9.CrossRefGoogle ScholarPubMed
Peet, MHorrobin, DFA dose ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002;59:913–20.CrossRefGoogle ScholarPubMed
Puri, BKCounsell, SJRichardson, AJHorrobin, DFEicosapentaenoic acid in treatment-resistant depression. Arch Gen Psychiatry 2002;59:91–2.CrossRefGoogle ScholarPubMed
Ramsay, RWard, ATreasure, JRussell, GFCompulsory treatment in anorexia nervosa. Short-term benefits and long-term mortality. Br J Psychiatry 1999;175:147–53.CrossRefGoogle ScholarPubMed
von Meyenfeldt, MFet al. Weight gain is associated with improved quality of life in patients with cancer cachexia consuming an energy and protein dense, high n-3 fatty acid oral supplement. Proc Am Soc Clin Oncology 2002;21:385A.Google Scholar
Submit a response

Comments

No Comments have been published for this article.